Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4742143
Max Phase: Preclinical
Molecular Formula: C16H20ClNO
Molecular Weight: 241.33
Molecule Type: Unknown
Associated Items:
ID: ALA4742143
Max Phase: Preclinical
Molecular Formula: C16H20ClNO
Molecular Weight: 241.33
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cccc(C)c1OCC(N)c1ccccc1.Cl
Standard InChI: InChI=1S/C16H19NO.ClH/c1-12-7-6-8-13(2)16(12)18-11-15(17)14-9-4-3-5-10-14;/h3-10,15H,11,17H2,1-2H3;1H
Standard InChI Key: FKYMGBCPNIRBKW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 241.33 | Molecular Weight (Monoisotopic): 241.1467 | AlogP: 3.38 | #Rotatable Bonds: 4 |
Polar Surface Area: 35.25 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.81 | CX LogP: 3.83 | CX LogD: 2.41 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.89 | Np Likeness Score: -0.43 |
1. Roselli M,Carocci A,Budriesi R,Micucci M,Toma M,Di Cesare Mannelli L,Lovece A,Catalano A,Cavalluzzi MM,Bruno C,De Palma A,Contino M,Perrone MG,Colabufo NA,Chiarini A,Franchini C,Ghelardini C,Habtemariam S,Lentini G. (2016) Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues., 121 [PMID:27267000] [10.1016/j.ejmech.2016.05.046] |
2. Cashman JR, Ryan D, McKeithan WL, Okolotowicz K, Gomez-Galeno J, Johnson M, Sampson KJ, Kass RS, Pezhouman A, Karagueuzian HS, Mercola M.. (2021) Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC Cardiomyocytes., 64 (9.0): [PMID:33942619] [10.1021/acs.jmedchem.0c01545] |
Source(1):